Companies 2

How Sun Pharma’s diverse business is helping it overcome US FDA curbs on manufacturing plants

Exports from Halol manufacturing plant continue to be restricted

IRCTC – Can it leverage the consumption push to gain speed?

Most of the businesses have matured and offer modest organic growth opportunities

Mahindra: GST tailwinds to power earnings across businesses segments

PV industry had gone through a rough patch between FY2022 and FY2023 when PV sales softened on the back of a surge in costs and vehicle prices

Chart of the Day: Soft demand hits thermal power plant utilisation in August

Thermal power plant utilisation levels declined to 61.7 percent in August 2025

Food delivery likely to get costlier on platform fee hike, GST levy

Swiggy has hiked its platform fee to Rs 15, inclusive of GST, in select markets. Rival Zomato has raised its platform fee to Rs 12.50 (excluding GST).

Business in the Week Ahead: September 8-12, 2025

Three new IPOs will open for subscription. US inflation and China exports are other data points to track.

What to expect from Indian equities, post GST 2.0?

It is unlikely to be a one-way street, given the conflicting forces at work

GST 2.0: Tax relief for green hydrogen, battery storage likely as meeting gets underway

The GST council will also look at reducing the tax on solar panels and windmill components from 12% to 5%

Why does this IT service growth leader merit attention?

Industry-leading earnings growth and the AI edge should help the stock do well

IndiGo tightens its grip over domestic market as Tata grapples with Air India

Akasa Air continues to see high occupancy levels

Chart of the Day: The transformation in RIL’s earnings

Retail, telecom and digital services together generated more than half of the company’s operating earnings in FY25

To tackle the fertiliser shortage, make domestic manufacturing lucrative

Companies in the private sector remain wary of committing large investments to urea manufacturing

Lost 95% revenues, 100% profits: Harsh Jain breaks silence on Dream 11 after real money gaming ban

Will VIP be able to overcome the rough patch with the change in ownership?

The company likely to report gradual improvement

Focus turns to execution at Hindustan Aeronautics as orders pour in

The company is expanding manufacturing and repair and overhaul facilities

Hyderabad's hospitality soars: Novotel HICC leads as MICE and green real estate powerhouse

Cherian highlighted that the MICE travel in Hyderabad has seen a 35 percent growth in 2024 alone, which, he said, is a strong indicator that the city is now firmly on the global events map. Over 75 percent of NHCC's annual revenue is MICE-driven.

Wipro bolsters its ER&D footprint with an acquisition

The transaction should add about 3 percent to the company’s top line

Renewable energy is also feeling the impact of climate change

Changing weather patterns are increasingly posing risks to renewable power generation

Smartphone maker Vivo expands ZEISS partnership under new imaging strategy

The initiative aims to make R&D in night photography, portraits, telephoto, and video, while expanding into health and cross-device applications.

Chart of the Day: Vishal Mega Mart’s value focus is yielding good results

Shares of the company almost doubled from its IPO in December 2024

Indian IT should take a leaf from Accenture’s M&A strategy

Accenture is using acquisitions to quickly scale-up in new growth areas

Ashok Leyland: Positioned for higher growth amid market recovery

The company exceeded expectations with better operational efficiencies

Business in the Week Ahead: August 18-22, 2025

Five new IPOs will open for subscription. Flash PMIs and minutes of US FOMC meeting are key data releases to track

After Kandla, L&T to build 1.8 million tonne green ammonia facility at Paradip port

L&T Energy Greentech plans to invest nearly Rs 80,000 crore to build its mega green hydrogen and green ammonia plants at Kandla and Paradip ports. It will soon tap the export market, starting with the Middle East, for its Made-In-India electrolysers, CEO Derek M Shah told Moneycontrol.

Cenexi turnaround brings Gland Pharma close to growth revival

Gland Pharma’s full year earnings are estimated to rise in FY26 after three consecutive years of declines